Skip to Main Content

Searching for ways to beat back rising drug costs, the Chilean legislature is advancing three measures — regulating prices, easing the mechanism for issuing a compulsory license, and creating a government web site to monitor pricing —that have alarmed the pharmaceutical industry.

One of the initiatives in particular has drug makers concerned. The proposed law, which last week passed the Health Commission, will allow the government to determine the price of a patented medicine based on whether the buyers have “economic accessibility.” In other words, if the drug is priced out of reach, the health ministry will have the right to cap its price.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!